Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nosocomial pneumonia].

Jean-Yves Fagon1

  • 1Service de réanimation médicale, Hôpital européen Georges Pompidou, 75015 Paris. jean-yves.fagon@hop.egp.ap-hop-paris.fr

La Revue Du Praticien
|June 30, 2004
PubMed
Summary
This summary is machine-generated.

Nosocomial pneumonia, a hospital-acquired lung infection, increases mortality and healthcare costs, especially in ICU patients. Early diagnosis and appropriate antimicrobial therapy are crucial for effective management and preventing drug-resistant infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In-hospital cardiac arrests admitted alive in intensive care units: Insights from the CubRéa database.

Journal of critical care·2022
Same author

Epidemiology and Predictors of Long-Stays in Medical ICU: A Retrospective Cohort Study.

Journal of intensive care medicine·2020
Same author

[Regulation of innovations in the field of e-health].

Medecine sciences : M/S·2018
Same author

Therapie·2018
Same author

Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2017
Same author

Outcomes in elderly patients admitted to the intensive care unit with solid tumors.

Annals of intensive care·2017
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Respiratory Medicine

Context:

  • Nosocomial pneumonia significantly impacts hospitalized patients, leading to increased mortality, extended hospital stays, and higher costs.
  • Incidence is notably higher in intensive care units (ICUs), post-operatively, and in patients requiring mechanical ventilation.
  • Pathogens causing nosocomial pneumonia are often multidrug-resistant, particularly in late-onset cases or following prior antibiotic exposure.

Purpose:

  • To differentiate true lung infections from lower respiratory tract colonization in suspected nosocomial pneumonia cases.
  • To accurately identify causative pathogens responsible for nosocomial pneumonia.
  • To guide the optimization of antimicrobial therapy selection and administration.

Summary:

Related Experiment Videos

  • Bronchoscopic techniques, including bronchoalveolar lavage and protected specimen brush, offer the highest sensitivity and specificity for diagnosing nosocomial pneumonia.
  • Prompt initiation of appropriate antimicrobial treatment is essential for patient outcomes.
  • Further research is needed to evaluate the efficacy of combination therapy and nebulized antibiotics, as well as to determine optimal treatment durations to prevent multidrug-resistant infections.

Impact:

  • Improved diagnostic accuracy for nosocomial pneumonia through bronchoscopic methods.
  • Timely and effective antimicrobial strategies to combat hospital-acquired infections.
  • Informing future clinical guidelines on managing multidrug-resistant pathogens in critical care settings.